A quality improvement project improving the value of iNO utilization in preterm and term infants.
J Perinatol
; 41(1): 164-172, 2021 01.
Article
em En
| MEDLINE
| ID: mdl-32770031
ABSTRACT
OBJECTIVE:
Inhaled NO (iNO) is used in the NICU for management of hypoxemic respiratory failure. The cost of iNO is significant and does not consistently improve outcomes in infants <34 weeks. PROJECTDESIGN:
Our team used The Model for Improvement to design a quality improvement project to utilize iNO for appropriate indications, ensure response to therapy and initiate timely weaning. The project was carried out at a Level IV NICU and successful interventions spread to a smaller Level III NICU.RESULTS:
This project demonstrated significant improvement in all measures; total iNO hours per month, average iNO hours per patient, and the percentage of prolonged iNO courses. With an estimated cost of $115/h, the cost per patient for iNO use declined by half from $21,620 to $10,580.CONCLUSIONS:
Our team improved the value of iNO utilization at our institution and spread successful interventions to another NICU in our network.
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Insuficiência Respiratória
/
Melhoria de Qualidade
Limite:
Humans
/
Infant
/
Newborn
Idioma:
En
Revista:
J Perinatol
Ano de publicação:
2021
Tipo de documento:
Article